Clinical experience with nintedanib for the treatment of IPF in 80 cases
M Kontou, V Bousgou, V Tzilas, E Bouros, S Tsipilis… - 2016 - Eur Respiratory Soc
Introduction: Nintedanib, is an intracellular inhibitor that targets multiple tyrosine kinases,
exerts its effect through the regulation of the PDGF, VEGF and FGF and has been recently …
exerts its effect through the regulation of the PDGF, VEGF and FGF and has been recently …